Infrequent amplification of JUN in hepatocellular carcinoma

Anticancer Res. 2009 Dec;29(12):4989-94.

Abstract

Aim: To determine whether JUN (the oncogene encoding c-Jun protein) is amplified and overexpressed in hepatocellular carcinoma (HCC).

Materials and methods: DNA copy number aberrations were investigated using a high-density oligonucleotide microarray. DNA copy numbers were determined by fluorescence in situ hybridization. Genomic DNA and mRNA were quantified using real-time quantitative PCR.

Results: A novel amplification was found at the chromosomal region 1p32-31 in a JHH-2 HCC cell line within which JUN is amplified and overexpressed. However, no copy number gain of JUN (>2-fold) was observed in 34 primary HCC tumors. Rather, a loss of JUN (<0.5-fold) was seen in 13 (38%) out of the 34 tumors and expression of JUN was significantly lower in 26 (70%) out of the 37 HCC tumors compared with their nontumorous counterparts.

Conclusion: Although JUN was amplified and overexpressed in JHH-2 HCC cells, amplification and overexpression of JUN may be rare in primary HCCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / pathology
  • Chromosome Aberrations*
  • Chromosomes, Human, Pair 1 / genetics
  • Gene Amplification*
  • Gene Dosage
  • Genes, jun*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • Nucleic Acid Hybridization
  • Oligonucleotide Array Sequence Analysis
  • Polymorphism, Single Nucleotide / genetics*
  • Tumor Cells, Cultured